BackProtagenic Therapeutics Overview

Protagenic Therapeutics Receivables

Track Protagenic Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Protagenic Therapeutics Receivables History

Loading

Protagenic Therapeutics vs. peers: Receivables Comparison

Loading

Protagenic Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Protagenic Therapeutics (PTIX) FAQ

Protagenic Therapeutics (PTIX) currently reports a receivables of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Protagenic Therapeutics's receivables history and peer comparisons.

Protagenic Therapeutics's receivables changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Protagenic Therapeutics reported $0 in receivables as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Protagenic Therapeutics, and consider following PTIX for alerts when major investors trade the stock.

Protagenic Therapeutics is classified in the Industrials sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing PTIX with unrelated industries.